| Theme |
Intraductal Papillary Mucinous Neoplasm (IPMN) |
| Title |
Surgical Treatment of Pancreatic Intraductal Papillary Mucinous Neoplasms |
| Author |
Takashi Hatori |
Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University |
| Author |
Akira Kimijima |
Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University |
| Author |
Izumi Fujita |
Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University |
| Author |
Toru Furukawa |
International Research and Educational Institute for Integrated Medical Sciences, Tokyo Women's Medical University |
| Author |
Toshihide Imaizumi |
Department of Surgery, School of Medicine, Tokai University |
| Author |
Masakazu Yamamoto |
Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University |
| [ Summary ] |
In the selection of surgical procedures which should be performed for intraductal papillary mucinous neoplasms (IPMN) when resection is indicated, the following issues must be considered ; direct invasion around the pancreas, lymph node metastasis and tumor spreading in the pancreatic duct. A pancreatectomy with lymph node dissection should be performed if the potential exists for extrapancreatic invasion. Limited pancreatic resection has a role in non-invasive IPMN treatment if extrapancreatic invasion has been ruled out preoperatively, or if a negative pancreatic cut end margin has been obtained during surgery. However, limited pancreatic resection is associated with numerous problems, including technical difficulties. A higher incidence of postoperative complications, including pancreatic fistulae, also exists. |